Myriad Genetics, Inc.
320 Wakara Way
Salt Lake City
Myriad Genetics Inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on three strategic imperatives: transitioning and expanding its hereditary cancer testing markets, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets.
CEO and Founder: Mark Capone
CMO (Medical): Richard Wenstrup
CFO: Bryan Riggsbee
CSO (Scientific): Jerry Lanchbury
Please click here for Myriad Genetics job opportunities.
Please click here for clinical trial information.
FOLLOW MYRIAD GENETICS: